Search Orphan Drug Designations and Approvals
-
| Generic Name: | (S)-2-methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy-1,1-d2)benzo[b]thiophen-7-yl)propanoic acid |
|---|---|
| Date Designated: | 02/12/2024 |
| Orphan Designation: | Treatment of autosomal dominant polycystic kidney disease (ADPKD) |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Shanghai Alebund Pharmaceuticals Ltd. 3rd Floor, Building 1, 400 Fangchun Road, Pilot Free Trade Zone Shanghai China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







